A FIRST HIGH-DEFINITION LANDSCAPE OF SOMATIC MUTATIONS IN CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS

EHA Library, Vanessa Rebecca Gasparini, 266162

UNDETECTABLE EXPRESSION OF WNT5A, A GENE ENCODING A ROR1 LIGAND, DEFINES MEMORY B-CELL LIKE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lucie Poppova, 266163

BORTEZOMIB LOWERS THE STAT3 PATHOGENETIC ROLE IN T-LGLL NEUTROPENIA DEVELOPMENT BY RESTORING MIR146B EXPRESSION

EHA Library, Giulia Calabretto, 266164

PROGNOSTIC IMPLICATIONS OF IGHV GENE REARRANGEMENTS WITH “BORDERLINE” PERCENTAGE OF MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Sara Raponi, 266165

CXCR5+PD-1+ CD8+ T-CELLS IN HUMAN BLOOD AND LYMPH NODES

EHA Library, Tom Hofland, 266166

MOLECULAR EVIDENCE THAT ATOVAQUONE IS A NEW STAT3-INHIBITOR COUNTERBALANCING LEUKEMIC CELL PRO-SURVIVAL IN LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 266167

DYSREGULATION OF BACH2 AND FOXP1 GENES IN T AND B CELLS IS MORE PRONOUNCED IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO AGED-MATCHED HEALTHY DONORS WITH AN IMPACT ON SURVIVAL

EHA Library, Dominique BRON, 266168

EXPLOITING IRON TOXICITY TO INCREASE VULNERABILITY OF MALIGNANT B CELLS

EHA Library, Jessica Bordini, 266169

SIGNAL-OMICS ANALYSIS OF THE IMPACT OF THERAPY ON BCR SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA.

EHA Library, Adam Linley, 266170

DNA METHYLTRANSFERASES GENE EXPRESSION LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA - IMPACT IN DEVELOPMENT, DIAGNOSIS AND PROGNOSIS

EHA Library, Ana Bela Sarmento-Ribeiro, 266171

INHIBITION OF BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEINS INCREASES SENSITIVITY TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Giovanna carrà, 266172

IMPACT OF ATM ALTERATIONS ON CHRONIC LYMPHOCYTIC LEUKEMIA IN GENERAL PRACTICE IN THE AREA OF NEXT GENERATION SEQUENCING

EHA Library, Sophie De Guibert, 266173

IBRUTINIB PLUS FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB (IFCR) AS INITIAL THERAPY FOR YOUNGER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE-ARM, MULTICENTER, PHASE 2 TRIAL

EHA Library, Matthew Davids, 266174

IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT FOR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). PRELIMINARY RESULTS FROM THE GIMEMA LLC1114 STUDY.

EHA Library, Francesca Romana Mauro, 266175

DIFFERENTIAL GENOMIC AND TRANSCRIPTOMIC EVENTS ASSOCIATED WITH HIGH-GRADE TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jenny Klintman, 266176

ACALABRUTINIB WITH OBINUTUZUMAB IN TREATMENT-NAIVE AND RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: 3-YEAR FOLLOW-UP

EHA Library, Jennifer Woyach, 266177

TREATMENT EMERGENT ADVERSE EVENTS VARY WITH DIFFERENT PI3K INHIBITORS

EHA Library, Farrukh Awan, 266178

PREVALENCE AND INCIDENCE OF CARDIOVASCULAR DISEASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A NATION-WIDE POPULATION-BASED STUDY.

EHA Library, Karin Larsson, 266179

SINGLE CELL ABNORMALITIES ON CLASSIC G-BANDING ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICOBIOLOGICAL FEATURES AND PROGNOSTIC VALUE

EHA Library, Anastasia Athanasiadou, 266180

FACTORS IMPACTING TREATMENT SELECTION IN TREATMENT-NAÏVE PATIENTS WITH CLL: A MULTICENTER STUDY

EHA Library, Joanna Rhodes, 266181

PROGNOSTIC MODELS FOR CHRONIC LYMPHOCYTIC LEUKEMIA: AN EXEMPLAR SYSTEMATIC COCHRANE REVIEW AND META-ANALYSIS (PRELIMINARY RESULTS)

EHA Library, Nina Kreuzberger, 266182

PROGNOSTIC TESTING AND TREATMENT APPROACHES BASED ON REAL-WORLD CLINICAL EXPERIENCE FROM AN INTERIM ANALYSIS OF THE INFORMCLL REGISTRY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anthony R. Mato, 266183

EFFECTIVENESS AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL-WORLD DATA (BIRD) STUDY

EHA Library, Ann Janssens, 266184

ANTICOAGULATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED WITH IBRUTINIB

EHA Library, William Archibald, 266185

HYPERTENSION IN PATIENTS TREATED WITH IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Lindsey Roeker, 266186

FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN FRANCE

EHA Library, Caroline Dartigeas, 266187

HAT-PCR IS MORE SENSITIVE THAN FLOW FOR QUANTIFYING MRD IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alexander Morley, 266188

PROGRESSION-FREE SURVIVAL PREDICTS OVERALL SURVIVAL IN FRONTLINE CLL

EHA Library, simona baculea, 266189

FIRST-LINE TREATMENT WITH LENALIDOMIDE DOES IMPROVE OUTCOME IN ELDERLY/UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Julia Driessen, 266190

INFLUENCE OF ATORVASTATIN THERAPY ON GALECTIN-3, VE-CADHERIN, AND CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Borys Samura, 266191

MONOCLONAL GAMMOPATHY AND HYPOGAMMAGLOBULINEMIA AS INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE MULTICENTRIC EXPERIENCE.

EHA Library, Andrea Corbingi, 266192

A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT-LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)

EHA Library, David Gottlieb, 266193

RHYTHM AND CONDUCTION DISORDERS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING TREATMENT WITH IBRUTINIB.

EHA Library, Elena Emelina, 266194

COMPLEX EVALUATION OF CELLULAR AND HUMORAL IMMUNITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lukáš Smolej, 266195

HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT TARGETS CALCINEURIN/NFATC1 SIGNALING AND ABROGATES THE RESISTANCE OF PH+ LEUKEMIA CELLS TO DASATINIB

EHA Library, Katia Beider, 266196

IDENTIFICATION OF PROTEIN-PROTEIN INTERACTIONS NECESSARY FOR MAINTENANCE OF BCR-ABL CORE COMPLEX

EHA Library, Tomas Gregor, 266197

KNOCKDOWN OF LASP1 IN CXCR4 EXPRESSING CML CELLS PROMOTES CELL PERSISTENCE, PROLIFERATION AND TKI RESISTANCE

EHA Library, Andreas B Herrmann, 266198

GENE EXPRESSION PROFILING OF CD26+ LEUKEMIC STEM CELL POPULATION FROM CML PATIENTS

EHA Library, Dagmar Smitalová, 266199

ANTI-LEUKEMIA EFFECT OF DISULFIRAM AND ASCORBATE IN ABL TYROSINE KINASE INHIBITOR RESISTANT LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 266200

IMMUNE SYSTEM AND CHRONIC MYELOID LEUKEMIA: THE IMPACT OF TYROSINE KINASE INHIBITORS

EHA Library, Ana Bela Sarmento-Ribeiro, 266201

PECULIARITIES OF THE EXPRESSION OF KI-67 AND CD34 HEMOPOIETIC PRECURSOR CELLS IN PB AND BM OF CML PATIENTS WITH THE DIFFERENT RESPONSES TO IMATINIB AND NILOTINIB THERAPY

EHA Library, Tetiana Perekhrestenko, 266202

NEGATIVE MR4.0 CHRONIC MYELOID LEUKEMIA AND ITS IMPLICATIONS FOR TREATMENT-FREE REMISSION

EHA Library, Nuno Cerveira, 266203

TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY

EHA Library, Simona Bernardi, 266204

DASCERN 2-YEAR EXTENDED FOLLOW-UP OF DASATINIB EFFICACY AND SAFETY IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WHO HAVE SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB

EHA Library, Giuseppe Saglio, 266205

PRIMARY THERAPY AND RELATIVE SURVIVAL AMONG ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2016.

EHA Library, Geneviève Ector, 266206

TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING FIRST-LINE DASATINIB, 1ST DADI/IMIDAS4

EHA Library, KAZUNORI MURAI, 266207

DASFREE 2-YEAR UPDATE: DASATINIB DISCONTINUATION IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND DEEP MOLECULAR RESPONSE (DMR)

EHA Library, Michael Mauro, 266208

DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER STOPPING FRONTLINE (1L) NILOTINIB: ENESTFREEDOM 192-WK RESULTS

EHA Library, David Ross, 266209

DOUBLING TIME AFTER FIRST ATTEMPT OF IMATINIB DISCONTINUATION IS HELPFUL TO IDENTIFY THE BEST CANDIDATE FOR THE SECOND ATTEMPT FOR TREATMENT-FREE REMISSION WITH DASATINIB: CANADIAN TRAD TRIAL

EHA Library, Dennis Kim, 266210

ENESTOP 192-WK RESULTS: DURABILITY AND IMPACT ON QUALITY OF LIFE OF TREATMENT-FREE REMISSION (TFR) FOLLOWING SECOND-LINE (2L) NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML)

EHA Library, François-Xavier Mahon, 266211

A PHASE 2 STUDY OF NILOTINIB (NIL) IN PEDIATRIC PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (CML): SAFETY UPDATE AFTER 36 CYCLES OF TREATMENT

EHA Library, Nobuko Hijiya, 266212

CARDIAC, VASCULAR, AND HYPERTENSION SAFETY OF BOSUTINIB VS IMATINIB FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN THE BFORE TRIAL

EHA Library, Tim H Brümmendorf, 266213

DNA-BASED BCR-ABL1 ANALYSIS PROVIDES A “TRAFFIC LIGHT” STRATIFICATION MODEL FOR CHRONIC MYELOID LEUKEMIA WITH IMPLICATIONS FOR TREATMENT FREE REMISSION

EHA Library, Katerina Machova, 266214

EFFICACY AND SAFETY FOLLOWING DOSE REDUCTION OF BOSUTINIB IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA: ANALYSIS OF THE PHASE 4 BYOND TRIAL

EHA Library, Tim H Brümmendorf, 266215

GROWTH RATE AND ENDOCRINE EFFECTS OF DASATINIB THERAPY OBSERVED IN A RETROSPECTIVE ANALYSIS OF A PHASE 2 CLINICAL TRIAL FOR PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

EHA Library, Briana Patterson, 266216

PONATINIB IN CHILDHOOD PHILADELPHIA POSITIVE LEUKEMIAS: THE EXPERIENCE OF THE INTERNATIONAL REGISTRY OF CHILDHOOD CHRONIC MYLELOID LEUKEMIA (I-CML-PED-STUDY).

EHA Library, Frederic MILLOT, 266217

TREATMENT-FREE REMISSION IN REAL-WORLD CHRONIC MYELOID LEUKEMIA PATIENTS: INSIGHTS FROM GERMAN CLINICAL HEMATOLOGY PRACTICES

EHA Library, Alexander Kiani, 266218

ANALYSIS OF THE INFLUENCE OF AGE ON MAJOR MOLECULAR RESPONSE,DEEP MOLECULAR RESPONSE AND SURVIVAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS (TKIS).

EHA Library, Luis Felipe Casado Montero, 266219

RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)

EHA Library, Anna Sicuranza, 266220

PLANNED PREGNANCY IN FEMALE PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITOR THERAPY

EHA Library, Qian Jiang, 266221

THE LONG-TERM TREATMENT RESULTS OF THE MULTICENTER EUTOS ELN POPULATION-BASED STUDY (EUTOS-PBS) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN RUSSIAN FEDERATION

EHA Library, Olga Lazareva, 266222

SAFETY OF IMATINIB AND ITS GENERICS IN CHRONIC MYELOID LEUKEMIA: A SUBANALYSIS OF POLISH IMATINIB GENERICS REGISTRY AFTER THREE YEARS OF OBSERVATION

EHA Library, Joanna Wącław, 266223

DISTINCT CYTOKINE PROFILES CHARACTERISE CML PATIENTS WHO HAVE HIGHER RISK OF EMR FAILURE AND BLAST CRISIS PROGRESSION

EHA Library, Liu Lu, 266224

PIEZO1 MEDIATED CALCIUM-INDUCED SIGNAL TRANSDUCTION IN ERYTHROBLASTS MODULATES ERYTHROPOIESIS

EHA Library, Francesca Aglialoro, 266225

GENOTYPE-RESPONSE CORRELATION IN DRIVE PK, A PHASE 2 STUDY OF MITAPIVAT (AG-348) IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY

EHA Library, Charles Kung, 266226

FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: INITIAL RESULTS OF THE OPEN-LABEL EXTENSION PERIOD OF THE SOAR PHASE 2 STUDY

EHA Library, David Kuter, 266227

GLUCOSYLSPHINGOSINE (LYSO-GL-1), A BIOMARKER OF GAUCHER DISEASE, CORRELATES WITH DISEASE SEVERITY AND RESPONSE TO ELIGLUSTAT IN 2 CLINICAL TRIALS OF TREATMENT-NAÏVE ADULTS WITH GAUCHER DISEASE TYPE 1

EHA Library, M. Judith Peterschmitt, 266228

MOLECULAR GENETIC STUDY OF ACUTE INTERMITTENT PORPHYRIA IN RUSSIA.

EHA Library, Maria Goncharova, 266229

EARLY POST-TRANSPLANTATION ANEMIA IS ASSOCIATED WITH MORTALITY OR GRAFT FAILURE IN LIVER TRANSPLANTED ADULTS

EHA Library, Tamar Berger, 266230

CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND THROMBOEMBOLIC RISK OF PATIENTS WITH COLD AGGLUTININ DISEASE (CAD) IN JAPAN

EHA Library, Jun-ichi Nishimura, 266231

EPIDEMIOLOGICAL SHIFT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) MUTATIONS IN NORTHERN ITALY DURING THE LAST 15 YEARS

EHA Library, Giovanna Graziadei, 266232

SOLUBLE MANNOSE RECEPTOR IS A POTENTIAL NEW BIOMARKER FOR PLASMA CELL DYSCRASIAS AND OTHER SKELETAL COMPLICATIONS IN GAUCHER DISEASE

EHA Library, Brendan Beaton, 266233

GLUCOPHOSPHATE ISOMERASE DEFICIENCY IDENTIFIED BY NEXT-GENERATION SEQUENCING

EHA Library, Sona M Vora, 266234

A FLEXIBLE THERAPEUTIC STRATEGY FOR LEUKEMIA USING EX-VIVO EXPANDED T CELLS COMBINED WITH BISPECIFIC ANTIBODIES

EHA Library, Josee Golay, 266235

GMP MANUFACTURING OF ALLOGENEIC CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) CYTOKINE INDUCED KILLER (CIK) CELLS WITH SLEEPING BEAUTY (SB) TRANSPOSON FOR ADOPTIVE IMMUNOTHERAPY

EHA Library, Giuseppe Gaipa, 266236

PLATINUM TALEN-MEDIATED NON-VIRAL T CELL RECEPTOR GENE KNOCK-IN FACILITATES UNIVERSAL T CELL GENOME EDITING FOR MANUFACTURING OF THERAPEUTIC IMMUNE CELLS

EHA Library, Yasuko Honjo, 266237

NKP30-BASED CHIMERIC ANTIGEN RECEPTOR REDIRECTED HUMAN T LYMPHOCYTES INDUCE EFFECTIVE ANTITUMORAL IMMUNE RESPONSES TO ACUTE MYELOID LEUKEMIA AND MELANOMA

EHA Library, Sophie Riedel, 266238

EXPLORING THE THERAPEUTIC POTENTIAL OF T-CELL-RECEPTOR REDIRECTED CD3+ NATURAL KILLER CELLS FOR ADOPTIVE CELLULAR THERAPY TO ACUTE MYELOID LEUKEMIA.

EHA Library, Jan Wernersbach, 266239

CAR T-CELL THERAPY: KNOWLEDGE GAPS AND EDUCATIONAL NEEDS FOR HEMATOLOGISTS/ONCOLOGISTS

EHA Library, Lauren Willis, 266240

RED BLOOD CELLS PROPERTIES IN PATIENTS WITH SICKLE CELL DISEASE TREATED WITH LENTIGLOBIN GENE THERAPY IN THE HGB-205 TRIAL

EHA Library, Elisa Magrin, 266241

TREATMENT WITH 5-AZACYTIDINE RESULTS IN EXPRESSION OF LONG TERMINAL REPEAT (LTR) ELEMENTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH MDS AND AML: FIRST PILOT STUDY.

EHA Library, Michael Daskalakis, 266242

ADOPTIVE IMMUNOTHERAPY OF INVASIVE ASPERGILLOSIS BY T CELLS VACCINES AGAINST ASPERGILLOSIS IN MOUSE MODEL

EHA Library, Haizhou Xing, 266243

IDENTIFICATION OF T-CELL RECEPTORS FROM THE ALLOGENEIC-HLA REPERTOIRE SPECIFIC FOR MELANOMA-ASSOCIATED ANTIGENS

EHA Library, Marije De Rooij, 266244

INHIBITION OF ACUTE LYMPHOBLASTIC AND MYELOID LEUKEMIAS BY NOVEL CHIMERIC MOUSE-HUMAN MONOCLONAL ANTIBODIES AGAINST ANTIGEN PRAME

EHA Library, Andrey Misyurin, 266245

EVALUATING EX VIVO EXPANSION OF FUNCTIONALLY COMPETENT MULTI-SPECIFIC T LYMPHOCYTES TO MINOR HISTOCOMPATIBILITY ANTIGEN FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Annabelle Minguy, 266246

IOVANCE PERIPHERAL BLOOD LYMPHOCYTES (PBL): A POTENTIAL CELL THERAPY STRATEGY FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lavakumar Karyampudi, 266247

EFFECTIVE STABILIZATION OF VIRAL VECTORS IN LIQUID USING AN ALGORITHM-BASED DEVELOPMENT APPROACH

EHA Library, Eva Reinauer, 266248

INACTIVATION OF THE NUCLEAR INTERACTING SET DOMAIN PROTEIN 1 IMPAIRS GATA1-REGULATED TERMINAL ERYTHROID MATURATION AND INDUCES ERYTHROLEUKEMIA

EHA Library, Marwa Almosailleakh, 266249

HIGH PLOIDY LARGE CYTOPLASMIC MEGAKARYOCYTES: KEY NEGATIVE REGULATORS OF HEMATOPOIETIC STEM CELLS AND ESSENTIAL FOR PLATELET PRODUCTION

EHA Library, Susie Nilsson, 266250

GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) IS REQUIRED FOR HEMATOPOIETIC STEM CELL FUNCTION

EHA Library, Oxana Bereshchenko, 266251

RUNX1 EXPRESSION IN NG2+ PERIVASCULAR CELLS IS REQUIRED FOR PROPER AORTIC EMBRYONIC HAEMATOPOIETIC ACTIVITY IN VIVO

EHA Library, Zaniah Gonzalez Galofre, 266252

TRANSCRIPTOME-PROTEOME CORRELATION IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Fabienne Meier-Abt, 266253

DENSE TEMPORAL PROFILING OF EPIGENETIC EVENTS REVEALS TWO DISCRETE PROGRAMS THAT GOVERN HUMAN ERYTHROPOIESIS

EHA Library, Grigorios Georgolopoulos, 266254

HETEROGENEITY IN EPIGENETICALLY REGULATED LIN28A-LET-7A-5P-ROS AXIS LEADS TO HETEROGENEITY IN MEGAKARYOCYTE MATURATION

EHA Library, Kazuya Hashimoto, 266255

BETA-CATENIN/TCF SIGNALING PATHWAY PROMOTES GRANULOCYTIC DIFFERENTIATION OF HEMATOPOIETIC PROGENITORS BY FACILITATING IL-1 RECEPTOR SIGNALING

EHA Library, Petr Daněk, 266256

MECHANISM OF MORPHOLOGICAL REMODELING OF BONE MARROW ADIPOCYTES IN ACUTE MYELOID LEUKEMIA

EHA Library, Shaoxin Yang, 266257

THIOPURINE-MEDIATED IMPAIRMENT OF HEMATOPOIEIC STEM AND PROGENITOR CELLS IN NUDT15R138C KNOCK-IN MICE AND POTENTIALITY OF NUDT15 GENOTYPE-BASED PRECISION MEDICINE FOR ACUTE LEUKEMIA

EHA Library, Goichi Tatsumi, 266258

ANGELICA SINENSIS POLYSACCHARIDE MAINTAINS THE FUNCTION OF HEMATOPOIETIC STEM CELLS BY REGULATING THE TREG/TH17 RATIO AND THEREBY INDUCES ANTI-MITOCHONDRIAL APOPTOSIS IN APLASTIC ANEMIA

EHA Library, Xing Cui, 266259

SINGLE CELL RNASEQ REVEALS THE IN VIVO DIFFERENTIATION POTENTIAL AND TRANSCRIPTIONAL DYNAMICS OF IMMATURE HUMAN THYMOCYTES.

EHA Library, Marieke Lavaert, 266260

DISTINCT CONTRIBUTIONS OF KAT2A HISTONE ACETYL-TRANSFERASE COMPLEXES TO HUMAN ERYTHROPOIESIS

EHA Library, Liliana Arede, 266261